Clinical Trials Browser

Phase 3 × Transplantation, Autologous × Plasma cell × Clear all

NCT00950768 2009-08-03

Melphalan 200 mg/m2 Versus Melphalan 100 mg/m2 in Newly Diagnosed Myeloma Patients

Phase 3 Completed

Disease, Multiple Myeloma, Neoplasms, Plasma Cell

NCT00560053 2008-11-27

Pethema Multiple Myeloma 2000

Phase 3 Completed

Multiple Myeloma